Showing results (131-140 of 424) with videos related to
Sort By:
Pageof 43
Oncology Reports|June 21, 2006
Enhancement of GLI1-transcriptional activity by beta-catenin in human cancer cellsOsamu Maeda, Masashi Kondo, Takayoshi Fujita, et al.Journal of Gastroenterology|July 2, 2008
Use of the Model for End-Stage Liver Disease (MELD) score to predict 1-year survival of Japanese patients with cirrhosis and to determine who will benefit from living donor liver transplantationMasatoshi Ishigami, Takashi Honda, Akihiko Okumura, et al.Oncology|May 4, 2018
Prognostic Factors Associated with Postprogression Survival in Advanced Hepatocellular Carcinoma Patients Treated with Sorafenib Not Eligible for Second-Line Regorafenib TreatmentTeiji Kuzuya, Masatoshi Ishigami, Yoji Ishizu, et al.Clinical Journal of Gastroenterology|April 28, 2017
Utility of Doppler ultrasonography for diagnosing and assessing treatment effects in liver compartment syndromeYusuke Ando, Masatoshi Ishigami, Yoji Ishizu, et al.Journal of Medical Virology|November 30, 2006
A mutation in the interferon sensitivity-determining region is associated with responsiveness to interferon-ribavirin combination therapy in chronic hepatitis patients infected with a Japan-specific subtype of hepatitis C virus genotype 1BMutsumi Murayama, Yoshiaki Katano, Isao Nakano, et al.Cancer Science|September 25, 2014
Silencing of STRN4 suppresses the malignant characteristics of cancer cellsMeihong Wong, Toshinori Hyodo, Eri Asano, et al.Stem Cells Translational Medicine|June 10, 2016
Multifaceted Therapeutic Benefits of Factors Derived From Dental Pulp Stem Cells for Mouse Liver FibrosisMarina Hirata, Masatoshi Ishigami, Yoshihiro Matsushita, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 31, 2017
Liver stiffness reduction correlates with histological characteristics of hepatitis C patients with sustained virological responseYoshihiko Tachi, Takanori Hirai, Yuko Kojima, et al.World Journal of Gastroenterology|June 15, 2006
Mutations in carboxy-terminal part of E2 including PKR/eIF2alpha phosphorylation homology domain and interferon sensitivity determining region of nonstructural 5A of hepatitis C virus 1b: their correlation with response to interferon monotherapy and viral loadKoji Ukai, Masatoshi Ishigami, Kentaro Yoshioka, et al.Journal of Gastroenterology and Hepatology|November 22, 2011
Clinical impact of HFE mutations in Japanese patients with chronic hepatitis CYoji Ishizu, Yoshiaki Katano, Takashi Honda, et al.Pageof 43